Trahan Jeremy 4

4 · VIEMED HEALTHCARE, INC. · Filed Feb 2, 2026

AI-generated summary of this filing

Updated Feb 2, 2026

Viemed (VMD) General Counsel Jeremy Trahan Receives Vesting Awards

What Happened

Jeremy Trahan, General Counsel of Viemed Healthcare, had equity awards vest on January 29, 2026. A total of 10,774 Restricted Stock Units (RSUs) vested; 2,939 of those shares were withheld by the company to cover taxes (value of withheld shares based on the Jan 29 closing price of $7.48 = $21,984). In addition, 3,591 phantom share units vested and were cash‑settled — the underlying common shares were effectively acquired and immediately disposed to the company for cash proceeds of $26,861 (3,591 × $7.48).
These transactions are awards/settlements (not open‑market purchases). Withholding of shares for tax and cash settlement of phantom units are routine administrative actions tied to vesting.

Key Details

Transaction date: January 29, 2026; Form 4 filed February 2, 2026 (filed within the two‑business‑day reporting window).
Per‑share price used for value calculations: $7.48 (closing market price on Jan 29, 2026).
RSUs vested: 10,774 shares; shares withheld for taxes: 2,939 shares (≈ $21,984).
Phantom units vested and cash‑settled: 3,591 units, cash proceeds ≈ $26,861.
Shares owned after the transaction: Not specified in the provided filing excerpt.
Notable footnotes: RSUs represent the right to one common share each (F1, F5); withheld shares satisfy tax obligations (F2); phantom shares are cash‑settled equivalents of common shares and were reported as simultaneous acquisition and disposition for cash (F4, F6).

Context

This was vesting and settlement activity (awards converted/settled), not an indicator of an open‑market buy or sell decision. The phantom units were cash‑settled (effectively a payout), and some RSU shares were withheld to pay taxes — both are common administrative outcomes of awards vesting.

Form 4

Period: 2026-01-29

General Counsel

Transactions

Exercise/Conversion
Common Shares
[F1]
2026-01-29+10,774→ 49,431 total
Tax Payment
Common Shares
[F2][F3]
2026-01-29$7.48/sh−2,939$21,984→ 46,492 total
Exercise/Conversion
Common Shares
[F4]
2026-01-29+3,591→ 50,083 total
Disposition to Issuer
Common Shares
[F3]
2026-01-29$7.48/sh−3,591$26,861→ 46,492 total
Exercise/Conversion
Restricted Stock Units
[F1][F5]
2026-01-29−10,774→ 10,773 total
Exp: 2027-01-29→ Common Shares (10,774 underlying)
Exercise/Conversion
Phantom Share Units
[F4][F6]
2026-01-29−3,591→ 3,591 total
Exp: 2027-01-29→ Common Shares (3,591 underlying)

Footnotes (6)

[F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
[F2]Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
[F3]Per share value is based on the market closing price of the common shares for January 29, 2026.
[F4]Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
[F5]Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.
[F6]Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

Signature

/s/ Jesse Bergeron, Attorney-in-Fact|2026-02-02

1 file